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Introduction
Asthma has a high prevalence of 5–10% 
(Eder et al. 2006), and in 2010 ranked as 
the 28th leading cause of disability-adjusted 
life years worldwide (Murray et al. 2012). 
Asthma is a heterogeneous disease that may 
appear at any age (most often in child-
hood), and can persist, possibly remit, or 
show variable activity over time (Strachan 
et al. 1996; Wenzel 2012). The complexity 
of this chronic disease is particularly chal-
lenging, and more research is needed on 
the environmental determinants of the 
disease (and not only on the acute triggers 
of attacks), because the increase in asthma 
incidence over the last decades (Eder et al. 
2006) strongly suggests a role of environ-
mental factors. The role of air pollutants in 
triggering asthma exacerbations in young and 
adult asthma patients is established (Peel et al. 
2005; Sunyer et al. 1997). Several studies 
support the role of air pollution in the devel-
opment of asthma in childhood (Anderson 
et al. 2013; McConnell et al. 2010), but 
not all (Mölter et al. 2015). The role of air 
pollution in adult-onset asthma (i.e., asthma 
incidence) has been investigated in only a 
few studies (Anderson et al. 2013; Jacquemin 
et al. 2012; Young et al. 2014) and should 
not be extrapolated from studies in children 
because childhood-onset and adult-onset 
asthma are two distinct asthma phenotypes 
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Background: Short-term exposure to air pollution has adverse effects among patients with asthma, but 
whether long-term exposure to air pollution is a cause of adult-onset asthma is unclear.
oBjective: We aimed to investigate the association between air pollution and adult onset asthma.
Methods: Asthma incidence was prospectively assessed in six European cohorts. Exposures studied were 
annual average concentrations at home addresses for nitrogen oxides assessed for 23,704 participants 
(including 1,257 incident cases) and particulate matter (PM) assessed for 17,909 participants through 
ESCAPE land-use regression models and traffic exposure indicators. Meta-analyses of cohort-specific 
logistic regression on asthma incidence were performed. Models were adjusted for age, sex, overweight, 
education, and smoking and included city/area within each cohort as a random effect.
results: In this longitudinal analysis, asthma incidence was positively, but not significantly, associ-
ated with all exposure metrics, except for PMcoarse. Positive associations of borderline significance were 
observed for nitrogen dioxide [adjusted odds ratio (OR) = 1.10; 95% CI: 0.99, 1.21 per 10 μg/m3; 
p = 0.10] and nitrogen oxides (adjusted OR = 1.04; 95% CI: 0.99, 1.08 per 20 μg/m3; p = 0.08). 
Nonsignificant positive associations were estimated for PM10 (adjusted OR = 1.04; 95% CI: 0.88, 1.23 
per 10 μg/m3), PM2.5 (adjusted OR = 1.04; 95% CI: 0.88, 1.23 per 5 μg/m3), PM2.5absorbance (adjusted 
OR = 1.06; 95% CI: 0.95, 1.19 per 10–5/m), traffic load (adjusted OR = 1.10; 95% CI: 0.93, 1.30 per 
4 million vehicles × meters/day on major roads in a 100-m buffer), and traffic intensity (adjusted OR = 
1.10; 95% CI: 0.93, 1.30 per 5,000 vehicles/day on the nearest road). A nonsignificant negative associa-
tion was estimated for PMcoarse (adjusted OR = 0.98; 95% CI: 0.87, 1.14 per 5 μg/m3).
conclusions: Results suggest a deleterious effect of ambient air pollution on asthma incidence in adults. 
Further research with improved personal-level exposure assessment (vs. residential exposure assessment 
only) and phenotypic characterization is needed.
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that have, at least partly, different clinical, 
biological, and genetic characteristics (Wenzel 
2012). Among studies in adults, only four 
have used individually assigned air pollu-
tion estimates at home addresses. A small 
Swedish case–control study (203 cases and 
203 controls) suggested an association of 
traffic-related nitrogen dioxide (NO2) with 
asthma incidence, but the study lacked 
statistical power (Modig et al. 2006). Both 
the Respiratory Health in Northern Europe 
(RHINE) study (3,824 participants) (Modig 
et al. 2009) and the European Community 
Respiratory Health Survey (ECRHS) (4,185 
participants) (Jacquemin et al. 2009b) 
reported a positive association between NO2 
and asthma incidence. The Swiss Study 
on Air Pollution and Health in Adults 
(SAPALDIA) found similar results, but only 
in never-smokers and using source-specific 
models of local traffic-related particulate 
matter (PM) as a marker of exposure (Künzli 
et al. 2009). A recent U.S. study suggested 
an association of PM2.5 (≤ 2.5 μm) with 
incident asthma in women (Young et al. 
2014). Two recent reviews concluded that 
the existing evidence suggests a possible role 
of air pollution in adult-onset asthma but 
that the evidence is not conclusive because 
the studies lacked of power, suggesting the 
need for larger cohorts (Anderson et al. 2013; 
Jacquemin et al. 2012).
The European Study of Cohorts for Air 
Pollution Effects (ESCAPE) developed, for 
the first time at large scale, fully standard-
ized air pollution measurement, modeling, 
and assignment methods to individually 
characterize home outdoor exposure (Beelen 
et al. 2013; Eeftens et al. 2012). We took 
advantage of a follow-up of > 10 years among 
23,704 adults in six prospective cohorts 
from eight countries to assess the association 
between long-term exposure to ambient air 
pollution and asthma incidence in adulthood.
Methods
Study population and assessment of asthma 
incidence. Six prospective cohorts from 
24 areas in eight countries contributed to the 
analysis of asthma incidence in adulthood 
over a 10-year period. Three of these cohorts 
[ECRHS (ECRHS II Steering Committee 
2002), the French Epidemiological study on 
the Genetics and Environment of Asthma 
(EGEA) (Siroux et al. 2009), and SAPALDIA 
(Ackermann-Liebrich et al. 2005)] were 
respiratory epidemiological cohorts, with 
detailed information regarding respiratory 
symptoms, bronchial challenge tests, and 
sensitization. The three others were general 
health cohorts. The study on the influ-
ence of Air pollution on Lung function, 
Inflammation and Aging (SALIA; Schikowski 
et al. 2010) and SAPALDIA were originally 
designed to investigate effects of air pollu-
tion. ECRHS, SAPALDIA, and the Medical 
Research Council’s National Survey of 
Health and Development (NSHD) (Kuh 
et al. 2011) corresponded to a representative 
sample of subjects of predefined areas. The 
Etude Epidémiologique auprès de femmes 
de la Mutuelle Générale de l’Education 
Nationale (E3N) (Clavel-Chapelon et al. 
1997) and SALIA were conducted in elderly 
women. EGEA included by design a high 
proportion of relatives of asthma patients 
recruited in chest clinics. ECRHS, EGEA, 
and SAPALDIA were initiated in the 1990s 
and followed-up 9–12 years later. NSHD is 
a birth cohort of participants born in 1946 
and with > 20 regular follow-ups since then; 
for this analysis, baseline was considered in 
1989 and follow-up in 1999. E3N women 
were recruited in 1990 and followed-up 
every 2 years; the last follow-up included for 
this analysis is the one from 2008. SALIA 
women were recruited in 1985; a question-
naire follow-up was conducted in 2006 and 
a second from 2007 to 2010. For detailed 
information on each study, see Supplemental 
Material, Table S1 and Figure S1. 
For each cohort, the absence of asthma 
at baseline and the incidence of asthma 
during follow-up were defined as shown in 
Supplemental Material, Table S2, according 
to the availability of each cohort’s variables. 
Two principles were followed regarding the 
assessment of asthma: harmonization across 
cohorts and optimal use of available informa-
tion. Depending on the cohort, asthma was 
defined by two standardized questionnaires: 
the British Medical Research Council ques-
tionnaire (Samet 1978), which originated in 
the 1960s, and the ECRHS questionnaire 
(Burney et al. 1994), designed in the 1990s. 
For all studies, asthma incidence was defined 
only in subjects without asthma at baseline. 
To further improve the specificity of our 
asthma incidence definition (Pekkanen et al. 
2005; Sunyer et al. 2007), we also excluded 
from the population at risk of new-onset 
asthma any participant who reported at 
baseline three of five asthma-like symptoms in 
the preceding 12 months (wheeze and breath-
lessness; chest tightness; attack of shortness 
of breath at rest; attack of shortness of breath 
after exercise; awakening by attack of short-
ness of breath); this information was available 
in three of the six cohorts (ECRHS, EGEA, 
SAPALDIA) (Boudier et al. 2013). (For flow 
charts and criteria used to classify asthma 
for each cohort, see Supplemental Material, 
Table S2 and Figure S1.) In ECRHS, 
SAPALDIA, and EGEA, objective asthma-
related traits were available. Methacholine 
bronchial provocation tests were performed 
and bronchial responsiveness defined when 
the provocative dose to decrease by 20% 
the forced expiratory flow volume in 1 sec 
was ≤ 1 mg cumulative dose of methacho-
line. Allergic sensitization was assessed as 
at least one skin prick test or at least one 
specific immunoglobulin E > 0.35 U/mL (see 
Table 1 for details). In all studies, hay fever 
was recorded by questionnaire at baseline 
and follow-up. Eczema was assessed in some 
studies. Moving status was defined based 
on the available data, considering addresses 
(geocodes) when baseline address was avail-
able and reported move assessed through 
questionnaire otherwise. Ethical approval 
was obtained for each cohort/center from the 
appropriate institutional or regional ethics 
committee, and written consent was obtained 
from each participant.
The covariates were chosen based on 
evidence from previous studies (Jacquemin 
et al. 2009b; Künzli et al. 2009; Modig et al. 
2009) but also taking into account the assess-
ment and quality of available data within the 
ESCAPE cohorts. Smoking (current, former, 
never), maximum educational level (low, 
medium, high), and overweight [body mass 
index (BMI) < 25, ≥ 25 kg/m2, except in 
ECRHS where an additional missing category 
was created because > 20% of data were 
missing for this variable] were considered in 
the analysis.
City/area refers to the city in ECRHS, 
EGEA, E3N, and SAPALDIA and the 
country in NSHD (England, Wales, and 
Scotland). All SALIA participants came 
from one area. 
Exposure data. Measurements of NO2/
NOx (nitrogen oxides) were conducted in 
three seasons in 2010 or 2011 using passive 
samplers in the 24 areas. Areas refers to cities 
(with or without their metropolitan areas) 
in most of the cases, except in the United 
Kingdom where it is the whole country and 
in the Ruhr region in Germany where it is 
an urban area including several cities. PM 
monitoring campaigns were conducted in 
12 areas. Exposure estimates at the partici-
pants’ addresses at follow-up [NO2, NOx, 
PM10 (≤ 10 μm), PM2.5, PM2.5absorbance, 
PMcoarse] derived from land use regression 
(LUR) models were used as primary exposure 
covariates (Beelen et al. 2014; Eeftens et al. 
2012; see also http://www.escapeproject.
eu). Back-extrapolated exposure estimates 
for NO2 and PM10 were used for sensitivity 
analyses because ESCAPE air pollution 
measurement campaigns took place after the 
health surveys for most cohorts. The back-
extrapolated concentration was estimated by 
multiplying the modeled ESCAPE annual 
mean concentration by the ratio between 
average annual concentrations as derived from 
the routine monitoring site(s) for the period 
in the past and for the ESCAPE measurement 
period time (Beelen et al. 2014). Exposures 
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were back-extrapolated to the follow-up 
period using routinely available air pollution 
monitoring data, but could not be extrapo-
lated to baseline for all the areas because of 
a lack of earlier monitoring data for some 
cities, particularly for PM10. Furthermore, 
baseline addresses were not available in all the 
cohorts. Traffic exposure indicators, traffic 
intensity (on the nearest road), and traffic 
load (in a 100-m buffer) were derived from 
geographic databases.
Data analysis. The following cohort-
specific random-effects logistic regressions 
were performed for all air pollution metrics: 
unadjusted (model 1), adjusted for age and 
sex (model 2), and additionally adjusted for 
smoking, overweight, and education level 
at baseline (model 3, the main model). Cox 
regression analysis was not used due to impre-
cision of the date of onset. The heterogeneity 
of the effect estimates between the cohorts 
was tested using the chi-square test. Meta-
analytic estimates were estimated using fixed-
effects models in the absence of heterogeneity 
between cohorts (p-value of heterogeneity 
> 0.1), and using random-effects models 
when heterogeneity between cohorts was 
present. The I2 statistic was calculated for 
quantifying heterogeneity. For meta-analyses 
of subgroups (age, sex, and smoking status), 
meta-analytic stratum-specific estimates 
were derived and were compared between 
strata. Cohort-specific estimates in subgroup 
analyses were conducted using model 3, but 
without taking into account random effects 
per city/area because random-effects models 
encountered convergence problems.
Because NO2 is not measured near busy 
roads, models of associations with traffic 
variables were adjusted for background NO2. 
Random effects were used for the main 
relevant cluster for each cohort (city/area for 
E3N, ECRHS, NSHD, and SAPALDIA, or 
family for EGEA).
Sensitivity analyses were conducted a) to 
address the robustness of the association to a 
change in the window of exposure (by using 
back-extrapolated NO2 and PM10); b) to 
address the possible impact of the exposure 
models’ performance [by restricting analyses 
to areas where exposure models had the 
highest predictive value (cross-validation R2 
> 0.6)]; c) to better compare the NO2 with 
the PM results (by restricting NO2 analyses 
to participants who also had PM measure-
ments); d) to unmask a possible effect of one 
pollutant over the other using a two-pollutant 
model (NO2 and PM10); e) excluding indi-
viduals with a self-reported age-at-onset 
≥ 2 years prior baseline according to record 
at follow-up, to better capture adult-onset 
asthma and not reappearance of childhood 
onset of asthma (Jacquemin et al. 2009b); 
this analysis is referred to as incidence with 
coherent age of onset in tables; f) excluding 
individuals with exposures at both upper 
and lower 5% extremes of pollutant values; 
and g) adjusting for “study city/area” as a 
fixed effect instead of random effect, as used 
before (Jacquemin et al. 2009b) but debated 
(Neuhaus and Kalbfleisch 1998). Stratified 
analyses were conducted by age (< 50 
or ≥ 50 years), sex, and smoking (ever- or 
never-smokers) and analyses restricted to 
nonmovers were conducted. We investigated 
the robustness of the meta-analyses estimates 
by excluding consecutively each cohort. 
We performed further analyses within the 
ECRHS cohort to allow direct comparison 
with a previous ECRHS publication 
(Jacquemin et al. 2009b) that estimated NO2 
Table 1. Characteristics of participants with NO2 exposure estimates in the ESCAPE analyses, by study (n) and outcome.
Characteristic
All (23,704) ECRHS (3,802) EGEA (517)a E3N (12,763) NSHD (2,339) SALIA (2,073) SAPALDIA (2,210)
No 
asthma
Incident 
asthma
No 
asthma
Incident 
asthma
No 
asthma
Incident 
asthma
No 
asthma
Incident 
asthma
No 
asthma
Incident 
asthma
No 
asthma
Incident 
asthma
No 
asthma
Incident 
asthma
n 22,447 1,257 3,657 145 468 49 12,012 751 2,245 94 1,925 148 2,140 70
Female (%) 82 89 52 67* 54 57 100 100 52 60 100 100 53 61
Age at baseline (years) (mean ± SD) 42 46 34 ± 7 34 ± 7 41 ± 12 36 ± 13* 49 ± 7 49 ± 6* 43 ± 0 43 ± 0 54 ± 1 55 ± 1 42 ± 12 38 ± 11*
Age ≥ 50 at baseline (%) 35 36 0 0 23 14* 43 38* 0 0 100 100 31 16*
Age at follow-up (years) (mean ± SD) 60 60 43 ± 7 42 ± 7 52 ± 12 47 ± 13* 65 ± 7 64 ± 6 53 ± 0 53 ± 0 71 ± 3 72 ± 3* 53 ± 12 49 ± 11
BMI at baseline (kg/m2) (mean ± SD) 23 24 24 ± 4 24 ± 5 23 ± 3 23 ± 5 22 ± 3 23 ± 3* 25 ± 4 27 ± 5* 27 ± 4 27 ± 4 24 ± 4 24 ± 4
BMI ≥ 25 at baseline (%) 26 30 33 35 26 31 13 18* 45 67* 67 66 31 29
Smoking status at baseline (%)
Current smoker 22 22 36 30 25 47* 17 19 26 29 11 16 36 24
Ever-smoker 29 29 21 26 24 10* 34 34 42 39 9 5 21 27
Never-smoker 49 49 43 45 51 43* 50 46 31 32 80 79 43 49
Maximum education at baseline or follow-up (%)
Low level 12 13 23 28 26 17 2 3* 41 51 22 25 7 9
Medium level 24 21 34 28 22 15 6 8* 48 42 49 51 62 60
High level 64 66 43 45 52 67 91 88* 11 8 29 24 30 31
Movers (between baseline and follow-up) (%) 33 33 45 42 45 55 27 31 39 37 18 15 48 50
Asthma-related variables
Methacholine test,b baseline (n) 4,837 197 2,871 112 385 38 NA NA NA NA NA NA 1,581 47
PD20 ≤ 1 mg (%) 9 28 8 38* 12 29* NA NA NA NA NA NA 9 6
Methacholine test,b follow-up (n) 3,499 147 2,197 94 264 25 NA NA NA NA NA NA 1,038 28
PD20 ≤ 1mg (%) 9 40 10 44* 12 48* NA NA NA NA NA NA 5 18*
SPT/spIgE,c baseline (n) 5,207 228 2,937 119 457 49 NA NA NA NA NA NA 1,813 60
Allergic sensitization (%) 27 50 25 52* 35 45 NA NA NA NA NA NA 28 50*
SPT/spIgE,c follow-up (n) 4,684 194 2,859 112 371 40 NA NA NA NA NA NA 1,454 42
Allergic sensitization (%) 27 55 24 55* 33 55* NA NA NA NA NA NA 30 55*
Hay fever at baseline (%) 13 26 19 46* 25 35 11 25* 16 19 5 10* 17 40*
Hay fever at follow-up (%) 11 27 21 54* 29 64* 5 17* 23 40* 5 19* 18 51*
Eczema at baseline (%) 34 43 33 43* 23 29 NA NA NA NA NA NA 38 51*
Eczema at follow-up (%) 27 36 35 48* 25 37 NA NA NA NA 4 13* 35 57*
Abbreviations: BMI, body mass index; NA, not available; PD20, dose of methacholine required to produce a 20% fall in the forced expiratory volume in 1 sec; SPT/splgE, skin prick test/
specific immunoglobulin E. Percentages are column percentages.
aIn EGEA, the 517 participants belong to 372 families, and 24% of the participants had at least one parent with asthma. bBronchial hyperresponsiveness was defined dichotomously 
as PD20 ≤ 1 mg [the common dose used in all three studies (ECRHS, EGEA, and SAPALDIA)]. cAllergic sensitization at baseline and follow-up for ECRHS, EGEA, and SAPALDIA was 
defined as at least one skin prick test (SPT) positive or at least one specific immunoglobulin E > 0.35 U/mL. In ECRHS, allergic sensitization was defined at baseline as any positive SPT 
(7 allergens tested) and allergic sensitization at follow-up was defined as any specific IgE concentration > 0.35 U/mL (4 IgEs tested). In EGEA and SAPALDIA, allergic sensitization at 
baseline or follow-up was defined as any positive SPT (EGEA: 11 and 12 allergens tested at baseline and follow-up, respectively; SAPALDIA: 8 allergens tested). *p < 0.05 comparing 
cohort participants with and without incident asthma. 
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using the APMoSPHERE (Air Pollution 
Modelling for Support to Policy on Health 
and Environmental Risk in Europe) model, 
a 1 × 1 km surface model developed using 
GIS-based techniques (Vienneau et al. 2009).
All the results are shown for an increase 
of 10 μg/m3 of NO2 and PM10, 5 μg/m3 of 
PM2.5 and PMcoarse, 10–5/m1 of PM2.5absorbance 
and 20 μg/m3 of NOx. For traffic measures, 
the results are shown for an increase of 
5,000 vehicles/day for traffic intensity on 
the nearest road and four millions vehicles × 
m/day for traffic load in major roads within a 
100-m buffer. Analyses used Stata version 12 
(StataCorp, College Station, TX, USA).
Results
Population. The six cohorts contributed to 
1,257 incident cases of asthma for the total 
population of 23,704 participants (Table 1). 
Cohorts differed by several characteristics, 
reflecting recruitment differences. Asthma 
incidence rates varied from 2.9/1,000/year 
in SAPALDIA to 8.3/1,000/year in EGEA. 
In the three cohorts (ECRHS, EGEA, 
SAPALDIA) with available data, participants 
who developed asthma after baseline (i.e., 
incident asthma cases) were more likely than 
other participants to be classified as having 
bronchial hyperresponsiveness (BHR) at 
baseline (28% vs. 9% with a positive metha-
choline test), and were even more likely to 
have BHR at follow-up (40% compared with 
9%). Compared with subjects who did not 
develop asthma, those with incident asthma 
exhibited more allergic sensitization, before 
(baseline) and after (follow-up) the onset 
of asthma. Hay fever was twice as common 
among participants with incident asthma 
compared with those without asthma (except 
for NSHD and EGEA at baseline).
Air pollution and traffic metrics. Mean 
and median air pollution exposures were 
lower for the NSHD cohort compared with 
the other five cohorts, though distributions 
overlapped among the cohorts (Figure 1; 
see also Supplemental Material, Table S3). 
The highest mean NO2 concentration was 
found in E3N (31 ± 13 μg/m3) and the 
lowest in NSHD (22 ± 7 μg/m3). For PM10, 
the highest mean concentration was found 
in SALIA (27 ± 2 μg/m3) and the lowest in 
NSHD (16 ± 2 μg/m3). Cohort-specific inter-
quartile ranges (IQRs) indicated substantial 
variability in the exposure contrasts within 
cohorts, ranging from 8 to 20 μg/m3 and 2 
to 8 μg/m3 for NO2 and PM10, respectively 
(see Supplemental Material, Table S3). The 
highest correlation coefficients were always 
seen between NO2 and NOx (r > 0.90) 
(see Supplemental Material, Table S4). 
Correlation coefficients between NO2 and 
PM10 varied from 0.53 in E3N to 0.83 in 
SAPALDIA. Correlation coefficients between 
the different air pollutant concentrations and 
the traffic indicators showed wide between-
cohort heterogeneity (from 0.06 for NO2 
and traffic intensity in NSHD to 0.81 for 
PM2.5absorbance and traffic load within a 
100-m buffer in EGEA) (Table S4). All the 
LUR models had a leave-one-out cross valida-
tion R 2 > 50%, and most of them > 80% 
(Beelen et al. 2013; Eeftens et al. 2012) (see 
Supplemental Material, Table S5).
Associations between air pollutants and 
traffic metrics and asthma incidence. The 
unadjusted, simple (adjusted by sex and age), 
and fully adjusted models provided similar 
results in individual cohorts (Table 2). The 
fully adjusted meta-analytic estimate for NO2 
was positive [odds ratio (OR) = 1.10; 95% 
confidence interval (CI): 0.99, 1.21; p = 0.10]. 
The association did not change when using the 
back-extrapolated NO2 ESCAPE estimates 
(OR = 1.10; 95% CI: 1.00, 1.20) (Table 2 
and Figure 2). When adjusting by city/area 
as a fixed effect (instead of random effect), 
the OR for NO2 increased to 1.14 (95% CI: 
1.01, 1.29) (Table 3), changes being driven 
mainly by an increased association estimate 
in ECRHS (OR = 1.41; 95% CI: 1.10, 1.80 
instead of OR = 1.07; 95% CI: 0.92, 1.23).
NO2 estimates were positive in all sensi-
tivity and stratified analyses (Table 3). Using 
the stricter definition of asthma incidence 
with coherent age of onset did not modify 
the associations but confidence intervals were 
wider as power was decreased (Table 3). The 
analyses that were restricted to nonmovers 
or that excluded the 5% extreme value of 
the pollutants tended to decrease the asso-
ciations (OR = 1.04; 95% CI: 0.98, 1.10 and 
OR = 1.03; 95% CI: 0.97, 1.10; respectively) 
(Table 3). Although cohort-specific association 
estimates suggested the possibility of between-
cohort differences, with stronger estimates 
in the French EGEA cohort compared with 
the others (Figure 2), heterogeneity among 
the cohorts was not statistically significant 
(Table 2). After consecutive exclusion of each 
cohort in the meta-analyses, the point estimate 
of the OR always remained positive, varying 
from 1.03 to 1.15, reaching significance for 
NO2 after the exclusion of E3N (OR = 1.15; 
95% CI: 1.03, 1.27 with a decreased heteroge-
neity between cohorts’ estimates) (Table 3) or 
SAPALDIA (OR = 1.11; 95% CI: 1.00, 1.24). 
A trend for stronger association between 
NO2 and asthma incidence was observed in 
ever-smokers compared with never-smokers 
(OR = 1.13; 95% CI: 0.99, 1.29 and 
OR = 1.01; 95% CI: 0.88, 1.16, respectively) 
(p-interaction = 0.35) (Table 3). Neither age 
nor sex modified the associations between 
Figure 1. NO2 and PM10 concentrations (μg/m3) by study. Boxes extend from the 25th to the 75th percentile, 
bars inside the boxes represent the median, and whiskers indicate the minimum and maximum values.
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NO2 and asthma incidence (p-interaction 
= 0.88 and 0.66, respectively) (Table 3). 
Restricting the analyses either to centers with 
both NO2 and PM10 measurements or to areas 
with a high goodness of fit of the LUR models 
did not modify the associations between NO2 
and asthma incidence.
For PM10, meta-estimates were similar and 
not significant in models with or without back-
extrapolation (OR = 1.04; 95% CI: 0.87, 1.24 
and OR = 1.04; 95% CI: 0.88, 1.23, respec-
tively) (Table 2). Except for PMcoarse, estimates 
were all positive but not significant, though 
borderline significant for NOx (OR = 1.04; 
95% CI: 0.99, 1.08) (Table 2).
PM10 estimates were positive and tended 
to increase in any sensitivity analysis, except 
when excluding EGEA, but never reached 
significance (Table 3). The analyses that 
were restricted to nonmovers or excluded the 
5% extreme value of the pollutants tended 
to increase the associations (OR = 1.12; 
95% CI: 0.91, 1.37 and OR = 1.11; 95% CI: 
0.89, 1.37, respectively). In the stratified 
analyses, slightly stronger associations between 
PM10 and asthma incidence were observed 
in ever-smokers compared with never-
smokers (OR = 1.17; 95% CI: 0.79, 1.74 
and OR = 1.01; 95% CI: 0.88, 1.16, 
respectively) and in women compared with 
men (OR = 1.07; 95% CI: 0.91, 1.26 and 
OR = 1.00; 95% CI: 0.63, 1.59, respectively), 
whereas associations were similar for age < 50 
and ≥ 50 years.
In the bi-pollutant model, the NO2 
estimate increased from 1.10 (95% CI: 
0.99, 1.21) to 1.17 (95% CI: 0.99, 1.38), 
whereas the PM10 estimate decreased from 
1.04 (95% CI: 0.88, 1.23) to 0.98 (95% CI: 
0.79, 1.21) (Table 3).
The comparison of ECRHS results using 
ESCAPE NO2 estimates or the previously 
published APMoSPHERE NO2 estimates 
(Jacquemin et al. 2009b) showed that the 
effect estimates were sensitive to both the 
analytic approach and the exposure models. 
Higher effect estimates were observed in the 
model with study/city used as fixed effect 
and/or when using the APMoSPHERE 
exposure model (see Supplemental Material, 
Table S6). For instance, the estimate based 
on the ESCAPE model and random effect 
on city was 1.04 (95% CI: 0.91, 1.20) and 
increased up to 1.94 (95% CI: 1.27, 2.96) 
in the model using the APMoSPHERE air 
pollution exposure and adjusted on city.
Discussion
In this longitudinal investigation, asthma 
incidence was positively associated with 
all exposure metrics, except with the 
coarse fraction of PM. The association 
was borderline statistically significant for a 
10-μg/m3 increase in NO2 (OR = 1.10; 
95% CI: 0.99, 1.21) and significant with 
back-extrapolated NO2 (OR = 1.10; 95% CI: 
Table 2. Meta-analyses of associations between air pollutants and traffic indicators and the risk for asthma incidence.
Exposure Increase
OR (95% CI)
Heterogeneity between 
cohorts (model 3)
Model 1 Model 2 Model 3 I 2 (%) p-Value
NOx, no. of participants 23,693 23,693 22,814
NO2 10 μg/m3 1.11 (1.00,1.23) 1.04 (0.99,1.09) 1.10 (0.99,1.21) 46.2 0.10
NO2 back-extrapolated to follow-up 10 μg/m3 1.10 (1.00,1.21) 1.04 (0.99,1.09) 1.10 (1.00,1.20) 49.6 0.08
NOx 20 μg/m3 1.09 (1.00,1.18) 1.04 (0.99,1.08) 1.04 (0.99,1.08) 39.8 0.14
PM, no. of participants 17,798b 17,798b 17,098b
PM10 10 μg/m3 1.05 (0.89,1.24) 1.05 (0.89,1.24) 1.04 (0.88,1.23) 0.0 0.44
PM10 back-extrapolated to follow-up 10 μg/m3 1.04 (0.88,1.24) 1.04 (0.88,1.24) 1.04 (0.87,1.24) 0.0 0.78
PMcoarse 5 μg/m3 0.98 (0.86,1.12) 0.98 (0.86,1.12) 0.99 (0.87,1.14) 0.0 0.61
PM2.5 5 μg/m3 1.11 (0.80,1.54) 1.04 (0.88,1.23) 1.04 (0.88,1.23) 24.2 0.25
PM2.5absorbance 10–5/m 1.05 (0.94,1.16) 1.05 (0.94,1.17) 1.06 (0.95,1.19) 44.5 0.11
Traffic variables, no. of participantsa 22,430 22,428 21,551
Traffic intensity on nearest road 5,000 vehicles/day 1.06 (0.98,1.14) 1.05 (0.98,1.13) 1.05 (0.98,1.13) 56.4 0.04
Traffic load in a 100-m buffer 4,000,000 vehicles × m/day 1.11 (0.94,1.31) 1.09 (0.94,1.27) 1.10 (0.93,1.30) 57.4 0.04
Model 1: unadjusted; model 2: adjusted for age and sex; model 3: adjusted for age, sex, smoking, overweight, and education level. The logistic regression models were conducted 
with random effects per city/area for each study except for SALIA, where there was only one area, and EGEA, where family structure was taken into account. The OR corresponds to 
the fixed effect when the p-value for heterogeneity was > 0.1; when the p-value for heterogeneity was < 0.1, the random effect is stated. I2: variation of estimate effect attributable to 
heterogeneity.
aFor traffic intensity on the nearest road. bFor PM10.
Figure 2. Associations of NO2 and NO2 back-extrapolated (per 10 μg/m3) on asthma incidence. Meta-
analysis from the study-specific adjusted random-effects logistic regression models. The logistic regres-
sion models were adjusted for age, sex, smoking, overweight, and education level (model 3) with random 
effects per city/area for each study except for SALIA, where there is only one area, and EGEA, where 
family structure was taken into account. I-V: inverse variance weighted (fixed effect) pooled estimate of all 
studies. I2: variation in estimate effect attributable to heterogeneity. D+L: DerSimonian and Laird (random 
effect) pooled estimate of all studies. Study-specific odds ratios are shown as solid black diamonds with 
horizontal lines representing 95% CIs. The size of the blue squares reflects the statistical weight of the 
study in the meta-analyses. The meta-analytic odds ratios are shown as open black diamonds, the middle of 
the diamond corresponds to the odds ratio value, and the width of the diamond represents the 95% CI.
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1.00, 1.20). Overall, these findings provide 
suggestive but not firm evidence for a role 
of ambient air pollution on asthma inci-
dence in adults.
The main strengths of this study are a 
large population from a wide geographical 
area, including > 23,000 participants from 
eight countries and > 20 different cities across 
Europe using standardized air pollution esti-
mates at the residential address for a variety 
of air pollutant metrics. This was achieved 
through a standardized procedure regarding 
air pollutants measurements, development 
of land use regression models, and validation 
(Beelen et al. 2013; Eeftens et al. 2012). The 
lack of highly significant associations in our 
findings is in line with three interpretations: 
namely, that there is no such association, that 
pollutants affect only subgroups of adults, or 
that we were unable to reliably capture such 
association as a result of epidemiological 
bias or lack of power. Overall the validity 
of those LUR models, assessed with the R2 
(see Supplemental Material, Table S5), were 
good, although this varied across study sites. 
We showed that restricting the NO2 analyses 
to the centers with higher R2 did not modify 
the results. A simulation study showed that 
LUR modeling with a small number of 
measurement sites may bias the health-effect 
estimates in the form of attenuation toward 
the null (Basagaña et al. 2013). The lack of 
association with PM may result partly from the 
small number of measurement sites for these 
pollutants. A further limitation was the long 
lag between the health assessments of most of 
our cohorts and the standardized ESCAPE 
measurement campaigns, reaching up to 
20 years in some of the cohorts. The resulting 
exposure misclassification likely contributed 
to imprecise risk estimates and a bias toward 
the null (Basagaña et al. 2013). To investigate 
this, back-extrapolated exposure estimates to 
the follow-up periods for NO2 were analyzed. 
The odds ratio using back-extrapolated values 
then reached formal statistical significance, 
but the effect size, which relied mainly on 
within-city contrasts, was virtually identical 
to that in the initial analysis. The validity 
of back- extrapolation of LUR models is 
supported by a study showing a good correla-
tion between the 1991 back-extrapolated NO2 
concentrations estimated from the 2009 LUR 
model and the NO2 concentrations measured 
by monitoring sites in 1991 (Gulliver et al. 
2013). However, back-extrapolated exposure 
estimates will not account for potential changes 
over time in spatial contrasts within cities, so 
their validity may vary by location and time. 
This is an inherent limitation of the ESCAPE 
project. Nevertheless, associations with other 
outcomes investigated in ESCAPE, including 
mortality (Beelen et al. 2014) and lung cancer 
incidence (Raaschou-Nielsen et al. 2013), have 
been similar for exposures based on ESCAPE 
measurement period estimates and exposures 
based on back-extrapolated estimates. 
Caution is necessary when interpreting 
our findings. Although positive, associations 
with PM and traffic proximity were nonsig-
nificant, which may indicate that these pollut-
ants do not affect adult-onset asthma or that 
the analyses lacked statistical power to reliably 
estimate small effects among rather hetero-
geneous cohorts. The fact that the positive 
associations with NO2 were the closest to 
statistical significance does not necessarily 
mean that NO2 is the causal pollutant. It 
could reflect that our exposure model more 
accurately estimates the true exposure for 
this pollutant [which is supported by a trend 
for a higher R2 cross-validation of the LUR 
model for NO2 compared with PM10 (Beelen 
et al. 2013; Eeftens et al. 2012)]. Further, 
given the correlation between pollutant 
concentrations, we cannot estimate associa-
tions with individual pollutants that account 
for potential confounding by other pollut-
ants. Moreover, no matter how good the 
exposure models are, there will always be 
Table 3. Results from random-effects meta-analyses for adjusted association between asthma incidence per 10-μg/m3 increase for NO2 and PM10: sensitivity 
and stratified analyses.
Analysis
No. of subjects OR (95% CI) from model 3a Heterogeneity between cohorts
NO2 PM10 NO2 PM10 I2 NO2 (%) p-Value I 2 PM10 (%) p-Value
Main analyses 22,814 17,098 1.10 (0.99,1.21) 1.04 (0.88,1.23) 46.20 0.10 0.00 0.44
Stratified analyses
By age*
Restricted to age < 50 14,875 10,499 1.08 (0.96,1.21) 1.07 (0.86,1.32) 56.60 0.06 10.60 0.35
Restricted to age ≥ 50 7,909 6,287 1.02 (0.94,1.12) 1.05 (0.78,1.42) 0.00 0.54 0.00 0.72
By sex**
Men only 4,098 2,264 1.06 (0.92,1.24) 1.00 (0.63,1.59) 0.00 0.45 0.00 0.61
Women only 18,725 14,751 1.07 (0.97,1.19) 1.07 (0.91,1.26) 0.45 0.11 0.00 0.51
By smoking status#
Ever-smokers only 11,664b 8,576 1.13 (0.99,1.29) 1.17 (0.79,1.74) 49.80 0.08 40.30 0.14
Never-smokers only 11,159b 8,433 1.01 (0.88,1.16) 1.10 (0.87,1.39) 50.00 0.08 0.00 0.52
Sensitivity analyses
Using asthma incidence definition with coherent age 
of onset (NSHD excluded)
19,935 14,585 1.09 (0.93,1.28) 1.07 (0.59,1.93) 65.40 0.02 64.10 0.03
Among nonmovers 15,289 11,780 1.04 (0.98,1.11) 1.12 (0.91,1.37) 0.00 0.50 0.00 0.88
Excluding E3N 10,715 7,185 1.15 (1.03,1.27) 1.17 (0.82,1.66) 11.90 0.34 8.30 0.36
Excluding ECRHS 19,014 15,151 1.12 (0.98,1.29) 1.13 (0.83,1.55) 56.50 0.06 15.40 0.32
Excluding EGEA 22,317 16,790 1.03 (0.98,1.09) 1.02 (0.86,1.20) 3.50 0.39 0.00 0.79
Excluding NSHD 20,624 15,121 1.08 (0.98,1.20) 1.06 (0.84,1.32) 49.10 0.10 13.80 0.33
Excluding SALIA 20,768 15,052 1.09 (0.98,1.21) 1.03 (0.85,1.26) 50.10 0.09 5.90 0.37
Excluding SAPALDIA 20,632 16,191 1.11 (1.00,1.24) 1.05 (0.89,1.24) 55.20 0.06 0.00 0.42
Excluding 5% upper and lower extreme values 20,642 15,412 1.03 (0.97,1.10) 1.11 (0.89,1.37) 0.00 0.92 0.00 0.84
Fixed effects between cities/areas within the same study 22,814 17,098 1.14 (1.01,1.29) 1.05 (0.86,1.29) 59.20 0.03 2.00 0.40
Restricted to cities/areas with both NO2 and PM10 17,097c 17,097c 1.11 (0.99,1.24) 1.04 (0.88,1.23) 39.40 0.14 0.00 0.44
Restricted to cities/areas with high goodness of fit for 
NO2 exposure models (R2 ≥ 0.6) 
21,048 NA 1.09 (0.98,1.21) NA 47.40 0.09 NA NA
Two-pollutant model (NO2, PM10) 17,097 17,097 1.17 (0.99,1.38) 0.98 (0.79,1.21) 46.20 0.10 0.00 0.42
NA, not applicable.
aMeta-analysis from the study-specific adjusted logistic regression models. The logistic regression models were adjusted for age (except for the model stratified by age), sex (except 
for the model stratified by sex), smoking (except for the model stratified by smoking), overweight, and education level (model 3). Random effects are given per city/area (except for the 
model considering city/area as fixed effect) for each study except for SALIA, where there is only one area, and EGEA, where family structure was taken into account. bInconsistent 
n due to NSHD: 11,664 + 11,159 = 22,823 ≠ 22,814. cInconsistent n due to ECRHS. *p-Value for interaction between participants < 50 and ≥ 50 years old for NO2: 0.88 and for PM10: 0.99. 
**p-Value for interaction between males and females for NO2: 0.66 and for PM10: 0.80. #p-Value for interaction between smokers and nonsmokers for NO2: 0.35 and for PM10: 0.69.
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limitations and potential bias in estimating 
association using exposure estimates only at 
home addresses that do not account for the 
individual spatiotemporal activity.
The design induces some limitation 
regarding the generalizability of our result 
to other European cities. For all cohorts, the 
first inclusion criterion was the availability of 
ESCAPE models, which varied from 20% for 
E3N (a national study) to 100% for SALIA 
and NSHD. At the whole cohort level, 
follow-up rates were less variable, varying 
between 60% and 80%, which represents a 
reasonable follow-up rate for such long-term 
studies (Ackermann-Liebrich et al. 2005; 
Antó et al. 2010; Kuh et al. 2011; Sanchez 
et al. 2013; Schikowski et al. 2010; Siroux 
et al. 2009). Though our study is the largest 
ever conducted in Europe, with the greatest 
number of countries and areas, and our esti-
mates did not indicate strong heterogeneity 
in associations across cohorts, some caution 
is needed in extrapolating our results, particu-
larly in relation to the heterogeneity between 
areas, and more importantly to the small 
sample size in each area.
Defining asthma incidence is more chal-
lenging than defining outcomes such as 
mortality (Beelen et al. 2014) or lung cancer 
(Raaschou-Nielsen et al. 2013). Furthermore, 
because adults may not remember early-life 
wheezing, assessment of adult-onset asthma 
is difficult (Strachan et al. 1996). A thorough 
comparison of questionnaires and protocols 
was undertaken to harmonize asthma defi-
nition across the various cohorts without 
losing valuable information. Although only 
ECRHS and SAPALDIA were purposefully 
designed to assess asthma incidence, we were 
as rigorous as possible in identifying only 
incident cases, by excluding participants 
who reported asthma or, when available, 
asthma-like symptoms at baseline from our 
study population. Bias in asthma diagnosis 
may have been introduced through both 
different cultural perceptions of asthma in the 
countries in which the cohorts were located, 
and the different questionnaires and diag-
nostic protocols used. In the largest cohort 
included, E3N, the validity of the simple 
asthma question used has been investigated 
in a subsample study, which showed good 
concordance with questions similar to those 
used in respiratory surveys and with dispensed 
asthma drug treatment (Sanchez et al. 2013). 
Because of a limited number of cohorts with 
bronchial challenge tests, we were unable 
to perform a sensitivity analysis defining 
asthma as new bronchial hyperresponsive-
ness plus symptoms, as used in a previous 
study of occupational risk factors for asthma 
(Kogevinas et al. 2007). However, for the 
three cohorts with information on bronchial 
hyperresponsiveness, the validity of our 
incident asthma classification was supported 
by the increase in bronchial hyperresponsive-
ness between baseline and follow-up among 
participants who developed asthma after the 
baseline examination.
Results should be interpreted in the 
context of current knowledge and research 
regarding asthma phenotypes. It is established 
that childhood-onset asthma, compared with 
adult-onset asthma, occurs more in males, is 
more often associated with allergic sensitiza-
tion, and also depends on specific genetic 
determinants (Bouzigon et al. 2008; Wenzel 
2012). With the increase of childhood asthma, 
the potential recurrence of asthma in adult-
hood after remission becomes an increasing 
concern. Recent research on asthma temporal 
patterns and data-driven phenotyping 
conducted in four of the six cohorts included 
in the present analysis show the complexity 
of asthma variability over periods of around 
10 years in adulthood (Boudier et al. 2013; 
Sanchez et al. 2013). Asthma in childhood 
only, adulthood only, old age only, mild 
(often forgotten) childhood asthma reap-
pearing in adulthood, or persistent asthma 
throughout the life span are various pheno-
types that may depend on both genetic 
and environmental determinants of various 
critical windows of expression/exposure. The 
variability of asthma can be characterized 
according to different windows of time (Frey 
and Suki 2008). These may be short (hours or 
days), often in relation to triggers of attacks, as 
well as long (months or years). Lessons from 
other environmental factors (smoking, occu-
pation) have already shown effects on asthma 
through acute or subchronic exposures. For 
example, there is increasing evidence of the 
role of occupational exposure in the various 
forms of work-related asthma, which encom-
passes both occupational asthma starting in 
adulthood and work-exacerbated asthma 
(Henneberger et al. 2011). The role of occupa-
tional exposure has clearly been evidenced in 
adult-onset asthma assessed in a birth cohort 
that was followed until adulthood (Ghosh 
et al. 2013). The follow-up of the numerous 
birth cohorts initiated in the 1990s and still 
followed will likely help us understand the 
various evolutions of the disease.
Our study considered multiple cohorts 
across Europe, which increased statistical 
power. However, this also gave potential for 
larger population heterogeneity, increasing the 
potential for confounding and therefore bias 
in the effect estimates. Particular characteris-
tics of each cohort may have influenced the 
results, such as the health consciousness and 
high education of the women in E3N or the 
greater baseline risk of asthma for members of 
asthmatic families in EGEA. Indeed, as shown 
in Figure 2, associations were usually largest 
in EGEA, reaching statistical significance for 
NO2—although this finding was not robust 
to the exclusion of the 5% most extreme 
exposure values (data not shown). To inves-
tigate cohort-specific influences on results, 
we formally tested heterogeneity among 
cohorts and also looked at the robustness of 
the findings by removing each cohort in turn, 
which showed some modest variation.
Overall, nearly all the sensitivity and strat-
ified analyses led to ORs > 1. Results from 
stratified analyses should be interpreted with 
caution because of the limited number of 
incident cases in subgroups in some cohorts, 
and none of the p-values for interaction were 
significant (p > 0.35). Surprisingly, the esti-
mates tended to decrease when restricting the 
analysis to nonmovers for NO2 but not for 
PM10. This could be attributable to the lower 
percentage of movers in E3N and the lack of 
standardization of moving assessment.
Our results were sensitive to the statistical 
approach chosen to account for the clustered 
data, namely using fixed versus random 
effects for study city/area. Which of the two 
modeling approaches provides more valid 
results is difficult to determine, but one factor 
may be the nature of the air pollutant varia-
tion in regards to the within- versus between-
city/area. Fixed city/area–effect models 
estimate purely within-city/area air pollu-
tion effects, whereas random-effects models 
estimate a weighted average of between- 
and within-city/area effects (Neuhaus and 
Kalbfleisch 1998). The difference between 
both approaches within our analyses was 
driven by the ECRHS estimates, possibly 
explained by the higher between-city/area 
variation in air pollutant concentration in this 
European cohort. Further analyses, including 
simulation studies, are warranted to better 
address this statistical issue in the context of 
the air pollution effect estimates.
Compared with other published results 
for NO2, our confidence intervals largely 
overlapped those from other studies [OR 
for 10 μg/m3 of NO2 = 1.10 (95% CI: 
0.99, 1.20) compared with 1.54 (95% CI: 
1.00, 2.36) in RHINE (Modig et al. 2009) 
and 1.43 (95% CI: 1.02, 2.01) in ECRHS 
(Jacquemin et al. 2009b) and OR for 5.8 ppb 
of NO2 (i.e., 11 μg/m3) = 1.12 (95% CI: 
0.96, 1.30) in a cohort of U.S. women 
(Young et al. 2014)]. Interestingly, the asso-
ciation with NO2 tended to increase when 
controlling for PM10 concentration. Two of 
the six cohorts included in our analyses had 
previously assessed associations between air 
pollution and asthma incidence in adults. In 
ECRHS, a positive and significant association 
was found between individually assigned air 
pollution exposure derived from a 1 × 1 km 
air pollution map (APMoSPHERE) and 
asthma incidence defined in a similar way 
to ESCAPE (Jacquemin et al. 2009b) and 
Jacquemin et al.
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also in an alternative way based on asthma 
symptoms (Jacquemin et al. 2009a). One 
possible reason for seeing consistently 
stronger associations with APMoSPHERE 
based analyses is that APMoSPHERE used air 
pollution data closer in time to the collection 
of health data. Alternatively, a spatially less 
resolved model may better account for the 
time activity patterns in adult populations; 
thus, “background” air pollutant exposure 
estimates could be a better proxy of the mean 
individual exposure compared with the very 
local exposure estimates at the home address, 
produced by the ESCAPE modeling strategy. 
SAPALDIA (Künzli et al. 2009) reported 
significant associations between asthma 
incidence in never-smokers and individually 
assigned changes in a specifically modeled 
marker termed “traffic related PM10.” 
ESCAPE had no such marker, so direct 
comparisons cannot be made. Moreover, 
only three SAPALDIA areas were included in 
ESCAPE—and only one with PM—whereas 
all previous SAPALDIA results were based on 
the eight areas the cohort had been designed 
for in 1990.
Various mechanisms have been proposed 
to explain the associations of air pollution 
with asthma. Active ongoing research is 
being conducted to disentangle the various 
asthma phenotypes and assess which mecha-
nisms may be specifically involved. Because 
childhood-onset asthma is more often associ-
ated with allergic sensitization, it could be 
hypothesized that allergy-related mecha-
nisms influence childhood asthma relapsing 
in adulthood. However, recent results from 
ESCAPE in children up to 10 years of age 
did not show evidence of associations of air 
pollution exposure with allergic sensitization 
(Gruzieva et al. 2014). This suggests that 
nonallergic mechanisms, for which interest is 
increasing for asthma at any age, are particu-
larly important to consider. Increased frailty 
of the epithelial barrier, inflammation, oxida-
tive stress, and interaction with genetic and 
epigenetic determinants have been proposed. 
Research in adults, including subjects from 
the cohorts included in our analysis, has 
suggested a role of air pollution in local 
inflammation measured in exhaled breath 
condensate and induced sputum (using 
ESCAPE exposure estimates) (Vossoughi 
et al. 2014), inter action with oxidative stress 
genes (Castro-Giner et al. 2009), or novel 
DNA methylation markers (Sofer et al. 
2013). Ambitious programs with comprehen-
sive environmental exposure assessment and 
biological markers are starting in childhood 
populations (Vrijheid et al. 2014). Altogether, 
adult-onset asthma is only one of the various 
asthma phenotypes, and comprehensive life 
course approaches should be developed at the 
environmental and phenotypic levels.
Conclusion
With > 23,000 adults across Europe followed 
for 10 years, including 1,257 incident cases of 
asthma, this is the largest study to estimate the 
association between traffic-related air pollution, 
assessed using a standardized and validated 
method at the individual level, and asthma 
incidence in adults. Our findings provide 
suggestive but no firm evidence for a role of 
air pollution exposure on asthma incidence in 
adults. Further research with improved indi-
vidual-level exposure assessment (taking into 
account, for example, time–activity patterns) 
and phenotypic characterization in a life-course 
perspective is needed to better understand the 
effect of air pollutants on asthma.
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